Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In a world-first initiative, Victoria is set to begin a trial allowing medicinal cannabis patients to drive on closed roads. The Victorian government aims to research the impact of cannabis on driving impairment, potentially paving the way for legal reforms. Starting in September, about 70 participants will drive at special facilities under instructor supervision. The
READ MOREGeorgia is set to implement new regulations on its burgeoning hemp industry, aiming to cap the amount of delta-9 THC in various cannabis products. The law, effective October 1, introduces strict limits on THC content in gummies, beverages, topicals, and tinctures. For instance, gummies cannot exceed 10mg of delta-9 THC per serving, while beverages are
READ MOREA groundbreaking clinical trial in Australia is exploring the potential of a new CBD-based capsule to combat insomnia. Conducted by Melbourne biotech company Avecho, the trial seeks to recruit 519 participants suffering from episodic insomnia—sleep disturbances lasting one to three months. The capsule, taken once daily before bed, contains cannabidiol (CBD), a compound known for
READ MOREIn a decisive move to safeguard public health, Missouri has announced a ban on the sale of Delta-8 THC and other hemp-derived intoxicants, effective September 1. This prohibition targets products such as drinks, candy, and other edibles infused with these substances, which have surged in popularity but remain largely unregulated. State officials expressed concerns over
READ MORECannabidiol (CBD), a non-psychoactive compound found in cannabis, is gaining attention for its potential to alleviate symptoms of ulcerative colitis (UC), a chronic inflammatory bowel disease. Some studies suggest CBD may help reduce inflammation and improve quality of life for UC patients, though the evidence remains inconclusive. Keith Sharkey, Ph.D., from the University of Calgary,
READ MOREA groundbreaking study by researchers from Charles Darwin University (CDU) and the Royal Melbourne Institute of Technology (RMIT) has revealed that a specific cannabis extract, known as PHEC-66, has a “deadly” effect on melanoma cells in laboratory settings. Published in the Cells journal, the study highlights how PHEC-66 induces apoptosis, or programmed cell death, in melanoma cells,
READ MORE